Scientists complete sequencing of maternal and paternal genomes

In a landmark achievement, an international consortium of scientists has successfully sequenced and distinguished between the maternal and paternal genomes, effectively completing the human genome sequencing effort initiated 23 years ago.

This groundbreaking research, published across 12 papers in journals like Cell and Cell Genomics, allows scientists to perfectly separate and reconstruct the genetic information inherited from both parents. Previously, distinguishing between maternal and paternal DNA relied on estimations based on appearance or limited genetic analysis. Now, researchers can pinpoint which chromosome in a pair carries the maternal lineage and which carries the paternal.

“

If the 2022 research was like putting together one puzzle, this work is like simultaneously completing two puzzles from a box where mom's and dad's puzzle pieces are randomly mixed.

The implications for medicine are profound. This ability to trace genetic variations to their source, mother or father, opens new avenues for understanding and treating genetic diseases. It is expected to be a significant milestone for personalized medicine, enabling more accurate diagnoses and tailored treatments.

“

This research signifies a paradigm shift in reconstructing an individual's entire genome, allowing us to accurately analyze every part of the genome without omission.

The project also revealed approximately 900 million new base sequences, about 15% of the total 6 billion bases, which were previously missing from the genome map. These newly identified regions have been linked to various conditions, including cancer, neurological disorders, and rare genetic diseases. The research team used the genome of a living human, 'HG002,' from a family set, which allowed for precise diploid genome sequencing.

Furthermore, the cost of sequencing the entire genome has plummeted. While the initial Human Genome Project cost $5 billion, sequencing the complete 6 billion base pairs now costs around $5,000. This dramatic reduction in cost, coupled with the ability to analyze complete diploid genomes, promises a future where comprehensive personal genomic information is routinely included in medical records, guiding lifelong health management.

“

In the future, analyzing an individual's entire genome will become commonplace, leading to an era where a baby's complete genome is attached to their medical records at birth, and lifelong health is managed based on this information.